Vatrix Medical Inc.

Early detection of abdominal aortic aneurysms - which are associated with degradation of the artery and result in weakening and expansion of the blood vessel that can lead to an often-fatal rupture - appears promising with a simple urine test being developed by Vatrix Medical Inc. The start-up is also introducing a minimally invasive endovascular procedure to slow AAA growth by treating the aneurysmal tissue with a novel class of stabilizing agents that bind directly to the diseased artery.